Graham Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6,052
| Closed | -$636K | – | 1425 |
|
|
2025
Q1 | $636K | Buy |
6,052
+1,054
| +21% | +$111K | 0.01% | 680 |
|
|
2024
Q4 | $536K | Buy |
+4,998
| New | +$536K | 0.01% | 685 |
|
|
2024
Q3 | – | Sell |
-6,040
| Closed | -$509K | – | 1192 |
|
|
2024
Q2 | $509K | Buy |
6,040
+1,183
| +24% | +$99.7K | 0.01% | 560 |
|
|
2024
Q1 | $355K | Buy |
+4,857
| New | +$355K | 0.01% | 702 |
|
|
2023
Q1 | – | Sell |
-5,876
| Closed | -$393K | – | 1199 |
|
|
2022
Q4 | $393K | Buy |
+5,876
| New | +$393K | 0.01% | 815 |
|